Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Revenue: 2023-2025

Historic Revenue for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to $3.3 million.

  • Tonix Pharmaceuticals Holding's Revenue rose 16.58% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 8.79%. This contributed to the annual value of $10.1 million for FY2024, which is 29.94% up from last year.
  • Tonix Pharmaceuticals Holding's Revenue amounted to $3.3 million in Q3 2025, which was up 64.66% from $2.0 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Revenue high stood at $4.0 million for Q3 2023, and its period low was $2.0 million during Q2 2025.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Revenue had a median value of $2.6 million in 2024 and averaged $2.8 million.
  • Per our database at Business Quant, Tonix Pharmaceuticals Holding's Revenue tumbled by 31.68% in 2024 and then increased by 16.58% in 2025.
  • Tonix Pharmaceuticals Holding's Revenue (Quarterly) stood at $3.8 million in 2023, then plummeted by 31.68% to $2.6 million in 2024, then grew by 16.58% to $3.3 million in 2025.
  • Its Revenue stands at $3.3 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.4 million for Q1 2025.